Abstract. Features of the tumor microenvironment (TME), such as hemoglobin saturation (HbSat), can provide valuable information on early development and progression of tumors. HbSat correlates with high metabolism and precedes the formation of angiogenic tumors; therefore, changes in HbSat profile can be used as a biomarker for early cancer detection. In this project, we develop a methodology to evaluate HbSat for forecasting early tumor development in a mouse model. We built a delta (δ) cumulative feature that includes spatial and temporal distribution of HbSat for classifying tumor/normal areas. Using a two-class (normal and tumor) logistic regression, the δ feature successfully forecasts tumor areas in two window chamber mice (AUC ¼ 0.90 and 0.85). To assess the performance of the logistic regression-based classifier utilizing the δ feature of each region, we conduct a 10-fold cross-validation analysis (AUC of the ROC ¼ 0.87). These results show that the TME features based on HbSat can be used to evaluate tumor progression and forecast new occurrences of tumor areas.
Introduction
Tumor progression and development can alter local metabolism, producing physiological changes in the tumor microenvironment (TME). Features associated with TME, such as development of new vessels, dilatation, deformation or destruction of existing vessels, oxygenation and hemoglobin saturation (HbSat), can provide valuable information on the progression of the tumor. 1, 2 For example, high metabolism, which is the characteristic of many cancers, produces early changes in levels of oxygenation around the tumor resulting in local changes of HbSat in tumor microvessels followed by a decrease in oxygenation in the central part of the tumor. 3 Several studies have shown that the HbSat is useful in distinguishing tumor areas from both normal fibro-glandular and adipose tissues. 4, 5 Other studies have shown that in spite of the intense angiogenesis, tumors can still be underserved with oxygen due to hyper metabolism of the cancer. [4] [5] [6] As the tumor progresses, the central low-oxygenated internal part of the tumor grows and microvessels around the margin of the tumor have a significant increase in HbSat. 3 This spatial distribution of HbSat is iterated because the tumor grows creating an HbSat profile from tumor proliferation to necrosis (areas with low HbSat). These changes in oxygenation and spatiotemporal distribution of the HbSat can provide insight in overall tumor progression 1, 7 and can be helpful in early tumor detection or the evaluation of response to treatment. Figure 1 shows a picture of a tumor developed from 4T1 mouse mammary carcinoma cells injected in a dorsal skin-fold window chamber in an anthymic nude mouse. The picture was taken 4 days after the implantation of 5000 tumor cells. The tumor cells were transfected with reporter genes of red fluorescence protein (RFP) for identification of the tumor location. The RFP vector was engineered by splicing the RFP coding sequence cloned from pDsRed2-N1 into pLPCX (BD Biosciences, San Jose, California) by EcoRI-NotI digestions as described in Ref. 8 .
In Fig. 1(b) , we can appreciate the high levels of saturation in the margin of the tumor compared with lower levels of saturation in the central part of the tumor (light blue). Outside the margin of the tumor, we can see high levels of HbSat as well. These areas of high HbSat outside the margin of the tumor indicate increased metabolism consistent with future tumor growth and show that the HbSat preceded the formation of the tumor. Analysis of temporal and spatial distributions of HbSat profile over the early development of the tumor can be useful for early cancer detection.
Aims and Contributions
The aim of this project is to develop a methodology based on image registration and segmentation for the analysis of HbSat for forecasting tumor development in a dorsal skin-fold window chamber. Toward this end, we use the spatial and temporal distribution of HbSat, though other features of TME can be analyzed in the same way.
We propose a new delta feature (δ) computed from the HbSat data over time, and showed that it is effective at forecasting future tumor occurrence in mouse models. In particular, a logistic regression-based classifier using our proposed new feature achieves AUC ¼ 0.87 in our cross-validation experimental study. This is potentially useful for early cancer detection.
Methodology
In this project, we work with two sets of images for each day during 5 days, gray-scale images [ Fig. 2(a) ] and data images [ Fig. 2(b) ]. The gray-scale image is a transmitted light image from which structural characteristics (e.g., vascularity) of tissue inside the window chamber can be evaluated. A data image is a pixel-wise mapping of HbSat values of blood vessels in the image.
The image datasets were obtained prior to this project by one of the authors in the laboratory of Mark W. Dewhirst (Duke University, Durham, NC). The procedure used to obtain the image data is described in Ref. 7 .
Spatial and temporal distribution of HbSat was determined by segmenting the images in windows of 20 × 20 pixels covering normal and tumor areas. The pixel resolution was about 3.5 μm with a pixel area of 12.25 μm 2 (the pixels were square). The 20 × 20 windows' size was selected after testing different window sizes (20, 50, and 100). The 20 × 20 windows' size was determined to be the most cost effective for this project. Bigger windows are easy to map and require less computational power, but smaller windows provide more accurate representation of the HbSat in the targeted region. Corresponding window areas over several days during the development of the tumor were compared to provide an HbSat profile. This information was used later to predict a tumor development in areas with no occurrence of tumor cells as yet.
The areas of newly developed tumors were determined by subtracting from the tumor areas of a particular day the tumor areas of previous days as follows: 
Registration
Since the structure of tissue and vascularity is not evident in the data images, the registration is performed in the gray-scale images and then projected to the data images for the purpose of HbSat evaluation. For the registration steps, we developed a graphical user interface "regGUI" (Fig. 3 ) based on the MATLAB® functions "cp2tform," "imtransform," and "imshowpair."
• The "cp2tform" function infers a spatial transformation from control point pairs (pixel coordinates) and returns this spatial transformation in a structure "t_concord" (see below).
t_concord=cp2tform(xyinput_out, xybase_out, "nonreflective similarity");
*xyinput_out: control points from the unregistered gray-scale image **xybase_out: control points from the base grayscale image
The control points (xyinput_out, xybase_out) were visually selected by translation and rotation of the unregistered image over the base image using the "regGUI" tool. The control points are pixel coordinates of similar features in both images.
Using the same control point pairs (xyinput_out, xybase_out), we can also reverse the registration process switching their positions in "cp2tform" producing the structure "t_concordReversed" that carries the spatial transformation information to reverse the registration. We call this process deregistration.
t_concordReversed=cp2tform(xybase_out, xyinput_-out, 'nonreflective similarity');
The structures "t_concord" and "t_concordReversed" are used in subsequent steps for mapping of the segmented areas (20 × 20 pixels) of the base data image with the unregistered data image.
Segmentation and Mapping
The segmentation of the images is based on a mesh of 20 × 20 pixel windows with the same dimensions of the base image. One copy of the mesh is deregistered using function "imtransform" with "t_concordReversed" as a parameter, as shown in Fig. 5 .
Another copy of the mesh is overlaid in the base image (Fig. 6, upper half) . The deregistered mesh from the previous step is overlaid in the unregistered image; in this case, the data image is for day 2 (Fig. 6, lower half) .
Subsequently, the base data and the unregistered data images (both with the overlaid mesh) are segmented/labeled based on the overlaid mesh (Fig. 7) using MATLAB functions "bwconncomp" and "labelmatrix."
conectedComp=bwconncomp(image_Data+Mesh); labelImage=labelmatrix(conectedComp); Using the original "t_concord" structure as the parameter in function "imtransform," the labeled image day 2 is registered ( Fig. 8) to match with the labeled image day 1.
Labeledreg=imtransform(Labeled-image-day-2, t_concord,
Since the registration was performed using the original "t_con-cord" structure, the windows of the mesh can be mapped in both images (days 1 and 2) using their center of mass ( Fig. 9 ) (MATLAB function "regionprops" with the centroid property). The corresponding regions for each day are stored in a matrix (Regions Fig. 5 A copy of the mesh is deregistered using the spatial transformation provided by "t_concordReversed" Fig. 6 The deregistered mesh is overlaid on the unregistered data image for day 2 (lower half), the original mesh is overlaid over the data image for day 1 (upper half). X Days), in which the regions correspond to the rows and the days correspond to the columns of the matrix as shown in Table 1 .
Region Classification: Ground Truth
The 20 × 20 pixel regions in the images were classified as normal (0), tumor (1), or unknown (3) for each day (Fig. 10) ; the classes of the regions were derived.
Tumor areas were identified using fluorescence from tumor cells transfected with constitutively expressed reporter genes for RFP. A mask created by using the fluorescent image was overlapped on the image data to locate the tumor areas. Since changes in HbSat preceded the formation of the tumor, and normal areas were selected in a region of the window chamber far away from the original inception of the tumor cells (Fig. 10) . All remaining areas were classified as unknown.
The classification of each region, e.g., normal, tumor, or unknown, was stored in a matrix similar to the mapped registered regions using day 1 as the reference for the region number (Table 2) . In all the experiments described later in this paper, we discarded all regions labeled "Unknown." Fig. 8 The labeled image day 2 is registered using the original "t_concord" structure. Fig. 9 Using the center of mass, the windows in the labeled base data image for day 1 on the left and labeled image for day 2 on the right can be mapped. For example, window 47 in day 1 corresponds to window 42 in day 2. 
Region Features
For each region/window r of 20 × 20 pixels in an image at day t, we fit, using maximum-likelihood estimation, a logistic distribution to the histogram of the region's pixel HbSat values.
Recall that the density function of the logistic distribution is given by the following equation:
The estimated mean μ ðrÞ t of this distribution is used as a feature of the region r at day t. We opted for the logistic distribution after a visual inspection of quality of fit of distributions to the histograms of the HbSat values of tumor and normal regions. The μ ðrÞ t feature for each region r for every day t was stored in a matrix along with the corresponding matching region (Table 3) .
Feature μ ðr Þ t
Since the μ ðrÞ t value is a representation of the HbSat distribution of each 20 × 20 pixel window, it can be used to correlate HbSat with the tumor presence for each day. The feature μ ðrÞ t was used to classify the regions as tumor or normal at day 4 [ Fig. 11(a) ] and at day 5 [ Fig. 11(b) ].
We classify regions as tumor or normal at day t using a twoclass logistic regression classifier logitðodds-ratio of tumor in region r at day tÞ ∼ 1 þ μ ðrÞ t ;
which implies that the probability of a tumor in region r at day t is Prob½tumor in region r at day t ¼ where the parameters a t and b t are estimated using the training data for day t. The logistic regression computes scores for each region, then we convert these scores to tumor/normal labels by comparing them to a threshold value. Then, we can assess the performance of this classifier by comparing the derived labels with the ground truth labels using receiver-operating-curve (ROC) analysis. The resulting ROC curves are shown in Fig. 11 , together with the area under the curve (AUC), for classifying regions as tumor/normal in day 4 [ Fig. 11(a) ] and in day 5 [ Fig. 11(b) ].
We can see in Fig. 11 that using the parameter μ ðrÞ t as a region's feature can discriminate very well between normal and tumor areas. These results were expected since there is previous research indicating that HbSat can distinguish malignant from normal tissue. 4 
Forecasting of Tumor Development in New Areas
As shown above, using μ ðrÞ t , it is possible to discriminate between tumor and normal areas in a particular day. However, since the increase of HbSat preceded the formation of tumor, it is interesting to know if μ ðrÞ t can also predict for areas which lack tumor on a particular day, which new areas will become tumors in subsequent days due to tumor growth. For example: Is it possible to predict new tumor areas in days 4 or 5 using HbSat readings from day 3? To tackle this question, we use μ ðrÞ t values from day 3 to classify areas as tumor in days 4 and 5. We compare our forecasting results with the ground truth classification provided by the fluorescence data. Tumor areas were selected using Eq. (1); normal areas were selected as previously described. As shown, we use logistic regression to classify regions as tumor/normal, and the results in ROC curves for the classification at days 4 and 5 using μ As is shown in Fig. 12 , parameter μ ðrÞ 3 does not seem very useful to predict the new tumor areas developed at day 5 (AUC ¼ 0.67). These results were expected since many areas labeled as tumors at day 5, which have values of HbSat under the threshold for tumors at day 3, and are misclassified as normal. Table 4 shows the examples of selected areas classified as tumors at day 5 by the fluorescence marker but with low μ Table 4 , we note a progressive increase in many regions, such as region 1911, where the μ ðrÞ t value increases from 11.08 at day 1 to 19.9 at day 3. Considering only the reading at day 3 μ ðrÞ 3 with a threshold value of 20, region 1911 would be misclassified as normal, but taking into consideration the increasing tendency of μ ðrÞ t over time, region 1911 could be classified as tumor at day 3 (even though at day 3 it is still below the threshold for a tumor).
Delta Feature (δ)
In order to better classify regions as tumor/normal, it is necessary to evaluate the variations of the t values across different days. Since HbSat in tumor regions usually increases progressively, using cumulative values could help to better classify the regions. For any given time period ½t s ; t f , and any region r reading between Ts and Tf was discarded from this analysis. The δ feature for each region is stored in a matrix using day 1 as a reference for the label on each region as shown in Table 5 .
Forecasting Tumor Areas in Day Five using (δ) Feature
We assess the capability of δ features by forecasting the occurrence of tumor by conducting the following experiment. We evaluate 97 normal areas along with 176 tumor areas, which are classified as normal/tumor at day 5, with valid μ ðrÞ t readings in days 1-3. The delta feature was used to classify the regions as tumor/normal at day 5. The δ ðrÞ 1→3 feature is used to classify regions as tumor/normal in day 5 by using a logistic regression model logitðodds-ratio of tumor in region r at day 5Þ ∼ 1 þ δ ðrÞ 1→3 .
The resulting ROC curve is shown in Fig. 13(a) . Using the same methodology, we repeat the experiment in a different mouse. We evaluate 61 normal areas along with 52 tumor areas, which are classified as normal/tumor at day 5, with valid μ ðrÞ t readings in days 1-3. The resulting ROC curve is shown in Fig. 13(b) .
Cross Validation Study
The contribution of this paper is the potential to forecast newly developed tumor areas using values of HbSat over a course of several days before the formation of the tumor (the δ ðrÞ t s →t f feature). Since using the δ ðrÞ t s →t f feature is a novel approach, it is necessary to evaluate its performance through a cross-validation study. We conducted a 10-fold cross-validation experiment to assess the performance of the logistic regression-based classifier utilizing the δ ðrÞ 1→3 feature of each region r to forecast the label of region r at day 5. Combining the tumor and normal areas of the two different mice in Sec. 6.2, we use 228 tumor areas along with 158 normal areas. We partitioned the regions in a stratified manner at random into 10 disjoint sets of regions. We used each group of nine sets of regions as a training set to build the logistic regression model using the δ ðrÞ 1→3 features of the training set. Then, using the regression model, we predicted the labels of the regions in the validation set (the 10th set of regions). We found that the AUC of the ROC is 0.87. We concluded that our proposed δ feature is effective at forecasting future tumor/normal regions. 
Conclusion
Forecasting of newly developed tumor areas at day 5 using HbSat data from days 1 to 3 using the δ ðrÞ 1→3 feature gives AUC ¼ 0.90 and AUC 0.85 in two different mice, and it is more effective than using the μ ðrÞ 3 feature alone. These results show that our proposed μ ðrÞ t and δ features based on HbSat are useful to evaluate tumor progression and forecast new occurrences of tumor areas. We demonstrated the advantages of utilizing HbSat readings on multiple days to create an HbSat profile over using a single standalone HbSat reading for detection of newly developed tumor areas.
Discussion
This project was envisioned as a proof of principle to show that analyzing HbSat profile as a tumor microenvironment feature makes it possible to evaluate development of tumor progression over time in a mouse model. We used the "window chamber" model since many of the variables related to tumor growth are controlled, e.g., type of tumor cell, number of tumor cells, original location of the tumor, etc., and the ease with which microvessels can be imaged in this model. In the clinical setting, some or none of these variables are known and, therefore, in order to evaluate tumor progression further studies must be performed in more realistic models, such as standard medical in vivo image technology, e.g., CT or PET. For example, PET imaging can indicate tissue metabolic activity through regional glucose uptake, and using the δ feature developed herein, the glucose profile over time may give an indication of future tumor progression. Therefore, the methodology used in this paper can be used as a base for further studies with other imaging modalities. In future research, we plan to analyze PET images using the same methodology to evaluate cancer regression after therapy.
